Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 463

1.

Complications after second trimester surgical and medical abortion.

Grossman D, Blanchard K, Blumenthal P.

Reprod Health Matters. 2008 May;16(31 Suppl):173-82. doi: 10.1016/S0968-8080(08)31379-2. Review.

3.

Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.

Gemzell-Danielsson K, Lalitkumar S.

Reprod Health Matters. 2008 May;16(31 Suppl):162-72. doi: 10.1016/S0968-8080(08)31371-8. Review.

5.

Surgical versus medical methods for second trimester induced abortion.

Lohr PA, Hayes JL, Gemzell-Danielsson K.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006714. doi: 10.1002/14651858.CD006714.pub2. Review.

PMID:
18254113
6.

A comparison of medical induction and dilation and evacuation for second-trimester abortion.

Autry AM, Hayes EC, Jacobson GF, Kirby RS.

Am J Obstet Gynecol. 2002 Aug;187(2):393-7.

PMID:
12193931
8.

A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.

Chai J, Tang OS, Hong QQ, Chen QF, Cheng LN, Ng E, Ho PC.

Hum Reprod. 2009 Feb;24(2):320-4. doi: 10.1093/humrep/den425. Epub 2008 Dec 1.

PMID:
19049993
9.

Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.

Shannon C, Wiebe E, Jacot F, Guilbert E, Dunn S, Sheldon WR, Winikoff B.

BJOG. 2006 Jun;113(6):621-8.

10.
11.

Misoprostol versus cervagem for the induction of labour to terminate pregnancy in the second and third trimester: a systematic review.

Dodd JM, Crowther CA.

Eur J Obstet Gynecol Reprod Biol. 2006 Mar 1;125(1):3-8. Epub 2006 Feb 7. Review.

PMID:
16466671
12.

Methods for induced abortion.

Stubblefield PG, Carr-Ellis S, Borgatta L.

Obstet Gynecol. 2004 Jul;104(1):174-85. Review.

PMID:
15229018
13.

Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.

von Hertzen H, Piaggio G, Wojdyla D, Marions L, My Huong NT, Tang OS, Fang AH, Wu SC, Kalmar L, Mittal S, Erdenetungalag R, Horga M, Pretnar-Darovec A, Kapamadzija A, Dickson K, Anh ND, Tai NV, Tuyet HT, Peregoudov A; WHO Research Group on Post-ovulatory Methods of Fertility Regulation.

BJOG. 2009 Feb;116(3):381-9. doi: 10.1111/j.1471-0528.2008.02034.x.

14.

Second-trimester induction of labor.

Vargas J, Diedrich J.

Clin Obstet Gynecol. 2009 Jun;52(2):188-97. doi: 10.1097/GRF.0b013e3181a2b5d5. Review.

PMID:
19407525
15.

Misoprostol for second trimester pregnancy termination in women with prior caesarean: a systematic review.

Berghella V, Airoldi J, O'Neill AM, Einhorn K, Hoffman M.

BJOG. 2009 Aug;116(9):1151-7. doi: 10.1111/j.1471-0528.2009.02190.x. Epub 2009 May 11. Review.

16.

Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases.

Rose SB, Shand C, Simmons A.

Aust N Z J Obstet Gynaecol. 2006 Dec;46(6):479-85.

PMID:
17116051
17.

Uterine rupture in second-trimester misoprostol-induced abortion after cesarean delivery: a systematic review.

Goyal V.

Obstet Gynecol. 2009 May;113(5):1117-23. doi: 10.1097/AOG.0b013e31819dbfe2. Review.

PMID:
19384128
18.

Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.

Akin A, Dabash R, Dilbaz B, Aktün H, Dursun P, Kiran S, Aksan G, Doğan B, Winikoff B.

Eur J Contracept Reprod Health Care. 2009 Jun;14(3):169-75. doi: 10.1080/13625180902916020.

PMID:
19565414
19.
20.

Supplemental Content

Support Center